BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37894533)

  • 1. Three Innovative Green and High-Throughput Microwell Spectrophotometric Methods for the Quantitation of Ceritinib, a Potent Drug for the Treatment of ALK-Positive Non-Small Cell Lung Cancer: An Application to the Analysis of Capsules and Drug Uniformity Testing.
    Abuhejail RM; Alzoman NZ; Darwish IA
    Molecules; 2023 Oct; 28(20):. PubMed ID: 37894533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of Two Novel One-Step and Green Microwell Spectrophotometric Methods for High-Throughput Determination of Ceritinib, a Potent Drug for Treatment of Anaplastic Lymphoma Kinase-Positive Non-Small-Cell Lung Cancer.
    Abuhejail RM; Alzoman NZ; Darwish IA
    Medicina (Kaunas); 2023 Oct; 59(10):. PubMed ID: 37893531
    [No Abstract]   [Full Text] [Related]  

  • 3. Development of Green and High Throughput Microwell Spectrophotometric Methods for Determination of Galidesivir in Bulk Drug and Dosage Forms Based on Simple Oxidimetric Reactions with Inorganic Agents.
    Darwish IA; Alzoman NZ; Abuhejail RM
    J AOAC Int; 2024 Mar; ():. PubMed ID: 38521540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development of Two Eco-Friendly and High-Throughput Microwell Spectrophotometric Methods for Analysis of an Antibacterial Drug Tulathromycin in Pharmaceutical Bulk Form.
    Darwish IA; Alzoman NZ; Alsalhi MS
    J AOAC Int; 2024 Apr; ():. PubMed ID: 38652601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel High-Throughput Microwell Spectrophotometric Assay for One-Step Determination of Lorlatinib, a Novel Potent Drug for the Treatment of Anaplastic Lymphoma Kinase (ALK)-Positive Non-Small Cell Lung Cancer.
    Al-Hossaini AM; Darwish IA; Darwish HW
    Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109714
    [No Abstract]   [Full Text] [Related]  

  • 6. Development and Validation of Green and High-Throughput Microwell Spectrophotometric Assay for the Determination of Selective Serotonin Reuptake Inhibitors in Their Pharmaceutical Dosage Forms.
    Darwish IA; Alzoman NZ
    Molecules; 2023 May; 28(10):. PubMed ID: 37241961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrophotometric Study of Charge-Transfer Complexes of Ruxolitinib with Chloranilic Acid and 2,3-Dichloro-5,6-dicyano-1,4-benzoquinone: An Application to the Development of a Green and High-Throughput Microwell Method for Quantification of Ruxolitinib in Its Pharmaceutical Formulations.
    Aljaber KA; Darwish IA; Al-Hossaini AM
    Molecules; 2023 Nov; 28(23):. PubMed ID: 38067605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and Comparative Evaluation of Two Different Label-Free and Sensitive Fluorescence Platforms for Analysis of Olaparib: A Recently FDA-Approved Drug for the Treatment of Ovarian and Breast Cancer.
    Darwish IA; Khalil NY
    Molecules; 2023 Sep; 28(18):. PubMed ID: 37764300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-Step Microwell Plate-Based Spectrofluorimetric Assay for Direct Determination of Statins in Bulk Forms and Pharmaceutical Formulations: A Green Eco-Friendly and High-Throughput Analytical Approach.
    Darwish IA; Darwish HW; Alzoman NZ; Ali AM
    Molecules; 2023 Mar; 28(6):. PubMed ID: 36985779
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a Green Microwell Spectrofluorimetric Assay with High Analytical Throughput for the Determination of Selective Serotonin Reuptake Inhibitors in Pharmaceutical Dosage Forms and Plasma.
    Alzoman NZ; Darwish IA
    Molecules; 2023 Jul; 28(13):. PubMed ID: 37446883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Charge Transfer Complex of Lorlatinib with Chloranilic Acid: Characterization and Application to the Development of a Novel 96-Microwell Spectrophotometric Assay with High Throughput.
    Darwish HW; Darwish IA; Ali AM; Almutairi HS
    Molecules; 2023 May; 28(9):. PubMed ID: 37175262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of Green and High Throughput Microplate Reader-Assisted Universal Microwell Spectrophotometric Assay for Direct Determination of Tyrosine Kinase Inhibitors in Their Pharmaceutical Formulations Irrespective the Diversity of Their Chemical Structures.
    Darwish IA; Alzoman NZ
    Molecules; 2023 May; 28(10):. PubMed ID: 37241790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo synergistic efficacy of ceritinib combined with programmed cell death ligand-1 inhibitor in anaplastic lymphoma kinase-rearranged non-small-cell lung cancer.
    Du P; Hu T; An Z; Li P; Liu L
    Cancer Sci; 2020 Jun; 111(6):1887-1898. PubMed ID: 32227409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Innovative use of σ and π electron acceptors in the development of three high throughput 96-microwell spectrophotometric assays for crizotinib.
    Darwish IA; Alzoman NZ; Alshehri JM; Darwish HW; Hamidaddin MA; Sayed AY
    Spectrochim Acta A Mol Biomol Spectrosc; 2021 Oct; 259():119884. PubMed ID: 33971436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spectrophotometric and computational investigations of charge transfer complexes of chloranilic acid with tyrosine kinase inhibitors and application to development of novel universal 96-microwell assay for their determination in pharmaceutical formulations.
    Darwish IA; Khalil NY; Darwish HW; Alzoman NZ; Al-Hossaini AM
    Spectrochim Acta A Mol Biomol Spectrosc; 2021 May; 252():119482. PubMed ID: 33571740
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development and validation of UPLC-MS/MS method for the simultaneous quantification of anaplastic lymphoma kinase inhibitors, alectinib, ceritinib, and crizotinib in Wistar rat plasma with application to bromelain-induced pharmacokinetic interaction.
    Maher HM; Almomen A; Alzoman NZ; Shehata SM; Alanazi AA
    J Pharm Biomed Anal; 2021 Sep; 204():114276. PubMed ID: 34325247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of Novel Micellar-Enhanced High-Throughput Microwell Spectrofluorimetric Method for Quantification of Lorlatinib: Application to In Vitro Drug Release and Analysis of Urine Samples.
    Al-Hossaini AM; Darwish HW; Bakheit AH; Darwish IA
    Pharmaceuticals (Basel); 2023 Sep; 16(9):. PubMed ID: 37765067
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and validation of spectrophotometric methods for determination of fluoxetine, sertraline, and paroxetine in pharmaceutical dosage forms.
    Darwish IA
    J AOAC Int; 2005; 88(1):38-45. PubMed ID: 15759724
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrophotometric Investigations of Charge Transfer Complexes of Tyrosine Kinase Inhibitors with Iodine as a σ-Electron Acceptor: Application to Development of Universal High-Throughput Microwell Assay for Their Determination in Pharmaceutical Formulations.
    Darwish IA; Darwish HW; Ali AM; Almutairi HS
    Medicina (Kaunas); 2023 Apr; 59(4):. PubMed ID: 37109733
    [No Abstract]   [Full Text] [Related]  

  • 20. ALTA-2: Phase II study of brigatinib in patients with ALK-positive, advanced non-small-cell lung cancer who progressed on alectinib or ceritinib.
    Kim ES; Barlesi F; Mok T; Ahn MJ; Shen J; Zhang P; Ou SI
    Future Oncol; 2021 May; 17(14):1709-1719. PubMed ID: 33569983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.